Ya‐Fen Tang
Ya‐Fen Tang publishes mostly in Epidemiology, Infectious Diseases and Molecular Medicine, on topics such as Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy and Antibiotic Use and Resistance.
- World rank
- #4,839,309 of 7,710,434 ranked researchers
- Rank in Taiwan
- #36,821 of 57,035
- Works
- 16
- Citations
- 483
- Citations per work
- 30.2
What does Ya‐Fen Tang research?
Ya‐Fen Tang's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (17%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences850.0%
- Medicine850.0%
- Everything else426.2%
- Life Sciences423.8%
- 1Epidemiology22% of their works
- 2Infectious Diseases17% of their works
- 3Molecular Medicine13% of their works
- 4Pharmacology11% of their works
- 5Applied Microbiology and Biotechnology6% of their works
- 6Molecular Biology4% of their works
Research topics
- Antibiotic Resistance in Bacteria
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotic Use and Resistance
- Urinary Tract Infections Management
- Mycobacterium research and diagnosis
- Pneumonia and Respiratory Infections
- Tuberculosis Research and Epidemiology
- Clostridium difficile and Clostridium perfringens research
Which keywords describe Ya‐Fen Tang's research?
The keywords of their largest research topics: Epidemiology, Antibiotic Resistance, Antimicrobial Resistance, ESKAPE Pathogens, Multidrug-Resistant Bacteria, Antibiotic Pharmacokinetics, Critically Ill Patients and Drug Resistance.
- Pneumococcal Conjugate Vaccine
- Mycobacterium tuberculosis
- Fecal Microbiota Transplantation
- Antibiotic-Associated Diarrhea
- Global Health
- Antimicrobial Stewardship
- Diagnosis
- Drug Resistance
- Antibiotic Pharmacokinetics
- ESKAPE Pathogens
- Antibiotic Resistance
- Epidemiology
- Antimicrobial Resistance
- Multidrug-Resistant Bacteria
- Critically Ill Patients
- Clinical Practice Guidelines
- Treatment
- Catheter-Associated Infections
- Urinary Tract Infections
- Community-Acquired Pneumonia
- Mycobacterium avium
- Nontuberculous Mycobacteria
- Tuberculosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Epidemiology146 topics
- Antibiotic Resistance113 topics
- Antimicrobial Resistance103 topics
- ESKAPE Pathogens61 topic
- Multidrug-Resistant Bacteria61 topic
- Antibiotic Pharmacokinetics51 topic
- Critically Ill Patients51 topic
- Drug Resistance52 topics
- Clinical Practice Guidelines42 topics
- Diagnosis42 topics
- Treatment42 topics
- Antimicrobial Stewardship31 topic
- Catheter-Associated Infections31 topic
- Global Health31 topic
- Urinary Tract Infections31 topic
- Antibiotic-Associated Diarrhea21 topic
- Community-Acquired Pneumonia21 topic
- Fecal Microbiota Transplantation21 topic
- Mycobacterium avium21 topic
- Mycobacterium tuberculosis21 topic
- Nontuberculous Mycobacteria21 topic
- Pneumococcal Conjugate Vaccine21 topic
- Tuberculosis21 topic
Where does Ya‐Fen Tang work?
Ya‐Fen Tang's main affiliation in the publication record is Kaohsiung Chang Gung Memorial Hospital, Taiwan.
How many publications and citations does Ya‐Fen Tang have?
OpenAlex counts 16 works and 483 citations for Ya‐Fen Tang, an h-index of 10, ranking #4,839,309 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ya‐Fen Tang. Posts are plain text and can be reported.